Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials
- PMID: 35482101
- PMCID: PMC10450020
- DOI: 10.1007/s00392-022-02013-2
Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials
Abstract
With growing experience, technical improvements and use of newer generation drug-eluting stents (DES), recent data showed satisfactory acute and long-term results after rotational atherectomy (RA) in calcified coronary lesions. The randomized ROTAXUS and PREPARE-CALC trials compared RA to balloon-based strategies in two different time periods in the DES era. In this manuscript, we assessed the technical evolution in RA practice from a pooled analysis of the RA groups of both trials and established a link to further recent literature. Furthermore, we sought to summarize and analyze the available experience with RA in different patient and lesion subsets, and propose recommendations to improve RA practice. We also illustrated the combination of RA with other methods of lesion preparation. Finally, based on the available evidence, we propose a simple and practical approach to treat severely calcified lesions.
Keywords: Calcified coronary lesions; Complex percutaneous coronary intervention; Rotational atherectomy.
© 2022. The Author(s).
Conflict of interest statement
Dr. Allali is a consultant for Boston Scientific. Dr. Abdel-Wahab declares that his hospital receives speaker’s honoraria and/or consultancy fees on his behalf from Boston Scientific and Medtronic. Dr. Hemetsberger is an honorary speaker for Boston Scientific. Dr. Richardt has received institutional research grants from St. Jude Medical, Biotronik and Medtronic. Dr. Neumann reports lectures fees paid to his institution from Amgen, Bayer Healthcare, Biotronic, Boehringer Ingelheim, Boston Scientific, Daiichi Sankyo, Edwards Lifesciences, Ferrer, Pfizer, Novartis; consultancy fees paid to his institution from Boehringer Ingelheim; grant support from Bayer Healthcare, Boston Scientific, Biotronic, Edwars Lifesciences, GlaxoSmithKline, Medtronic and Pfize. The other authors have no conflicts of interest to declare.
Figures





References
-
- Ritchie JL, Hansen DD, Intlekofer MJ, Hall M, Auth DC. Rotational approaches to atherectomy and thrombectomy. Z Kardiol. 1987;76(Suppl 6):59–65. - PubMed
-
- Abdel-Wahab M, Richardt G, Joachim Buttner H, Toelg R, Geist V, Meinertz T, Schofer J, King L, Neumann FJ, Khattab AA. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (rotational atherectomy prior to taxus stent treatment for complex native coronary artery disease) trial. JACC Cardiovasc Interv. 2013;6(1):10–19. doi: 10.1016/j.jcin.2012.07.017. - DOI - PubMed
-
- Abdel-Wahab M, Toelg R, Byrne RA, Geist V, El-Mawardy M, Allali A, Rheude T, Robinson DR, Abdelghani M, Sulimov DS, Kastrati A, Richardt G. High-speed rotational atherectomy versus modified balloons prior to drug-eluting stent implantation in severely calcified coronary lesions. Circ Cardiovasc Interv. 2018;11(10):e007415. doi: 10.1161/CIRCINTERVENTIONS.118.007415. - DOI - PubMed
-
- Kinnaird T, Gallagher S, Spratt JC, Ludman P, de Belder M, Copt S, Anderson R, Walsh S, Hanratty C, Curzen N, Banning A, Mamas M. Complex high-risk and indicated percutaneous coronary intervention for stable angina: does operator volume influence patient outcome? Am Heart J. 2020;222:15–25. doi: 10.1016/j.ahj.2019.12.019. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical